Intrinsic Value of S&P & Nasdaq Contact Us

Cardinal Health, Inc. CAH NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
56/100
1/7 Pass
SharesGrow Intrinsic Value
$293.86
+36.7%
Analyst Price Target
$252.33
+17.4%

Cardinal Health, Inc. (CAH) generated $2.4B in operating cash flow for fiscal year 2025. After capital expenditures of $547M, free cash flow was $1.85B.

Free cash flow margin was 0.8% of revenue. Cash conversion ratio was 1.53x, indicating earnings are backed by cash.

The company returned $494M in dividends and $765M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was 1.53x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 56/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
~
VALUE
45/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
58/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
49/100
Proven by this page
GROWTH
83/100
→ Income
INCOME
30/100
→ Income
Cardinal Health, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $6.1B$2.4B$3.76B$2.84B$3.12B
Capital Expenditure $-597M$-547M$-511M$-481M$-387M
Free Cash Flow $5.51B$1.85B$3.25B$2.36B$2.74B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message